20010406
 Study Says Drug Firms Evade Rules That Give Best Prices to Medicaid   By By Sarah Lueck, The Wall Street Journal,  Apr 6, 2001  Repackagers, which buy drugs for resale in different quantities or under their own brand names, are excluded from Medicaid's best-price provision. HMOs aren't exempt from best-price rules, even when they act as repackagers.  Seven out of 53 companies, none of which were identified in the report, sold drugs to eight repackagers for prices below the best prices. But three of the eight repackagers were HMOs.  The Health Care Financing Administration, the agency that administers Medicaid, recently issued a clarification saying that sales to HMOs functioning as repackagers fall under best-price rules.   
